Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

For some people, diet, and exercise are not enough to lose weight and keep it off. This is where weight loss medication, ...

Type 2 diabetes and obesity are intimately linked; reduction of bodyweight improves glycemic control, mortality and morbidity. Treating obesity in the diabetic is hampered as some diabetic ...

--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today that QSYMIA® (phentermine and topiramate ... momentum in weight loss solutions ...

Approved by the U.S. FDA in 2012, QSYMIA is the leading non-injectable branded weight loss medication in the U.S. for adults. QSYMIA is a combination of phentermine, a sympathomimetic amine anorectic, ...

QSYMIA is the leading non-injectable branded weight loss medication in the U.S. for adults. QSYMIA is a combination of phentermine, a sympathomimetic amine anorectic, and topiramate, indicated in ...

The drugs, which moderate blood glucose levels and create a sense of satiety, or fullness, were approved for teens aged 12 and up specifically for weight loss just a few years ago. Pediatricians ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Pharmacies currently making copycat versions of Eli Lilly’s tirzepatide face heightened exposure to state enforcement actions and legal challenges while the FDA reconsiders whether or not there is a ...

If you’ve been on the lookout for an effective weight loss supplement, chances are you’ve come across Puravive reviews that highlight its unique approach to boosting metabolism and burning fat. Like ...

An ordinary loss is loss realized by a taxpayer when expenses exceed revenues in normal business operations. Ordinary losses are those losses incurred by a taxpayer that are not capital losses.

EVERETT, Wash. (AP) — Boeing reported a third-quarter loss of more than $6 billion before turning its attention to whether striking factory workers would accept a contract offer Wednesday and ...